Tag Archives: Valeant

Valeant Eye Drop Approval Held Up Over Manufacturing Concerns Following FDA Inspection

July 26, 2016 By: Irvin Jackson

The FDA has issued a letter to Valeant indicating that a Bausch and Lomb facility in Florida has failed to meet current good manufacturing practices, potentially holding up a new…
Drug Company Advertising Skyrocketed In 2015: Report

July 08, 2016 By: Irvin Jackson

The pharmaceutical industry is expanding its advertising spending at a rate faster than any other industry, at a time when some health experts say direct-to-consumer ads for prescription drugs should…
Potiga Risk of Vision Loss, Skin Discoloration Require New Long-Term Study

June 17, 2015 By: Irvin Jackson

The FDA has ordered the makers of Potiga to conduct a long-term study on skin discoloration and retina pigment changes caused by the epilepsy drug.

More Than 60,000 Camp Lejeune Water Poisoning Claims Submitted by Injured Veterans, Family Members: Report (Posted 7 days ago)

A new report indicates the U.S. Navy is struggling to process tens of thousands of Camp Lejeune water poisoning claims due to a lack of resources.

Motion Filed to Centralize Bard Implanted Port Lawsuits in Federal Court System (Posted 7 days ago)

A group of plaintiffs have filed a motion with the U.S. JPML seeking consolidation of all Bard implanted port lawsuits before one judge for pretrial proceedings.

Hearing Loss Lawsuit Filed Against Tepezza Manufacturer Over Failure to Warn (Posted 8 days ago)

A Tepezza hearing loss lawsuit accuses the manufacturer of failing to provide adequate warning about the risks of the thyroid eye disease drug.

Tag Archives: Valeant

Valeant Eye Drop Approval Held Up Over Manufacturing Concerns Following FDA Inspection

Drug Company Advertising Skyrocketed In 2015: Report

Potiga Risk of Vision Loss, Skin Discoloration Require New Long-Term Study

More Top Stories

Review A Case